• S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

  • May 7 2021
  • Durée: 25 min
  • Podcast

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

  • Résumé

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.

    Voir plus Voir moins

Ce que les auditeurs disent de S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.